1. Xue M, Xu W, Ou YN, et al. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944.
2. Lee AK, Rawlings AM, Lee CJ, et al. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study. Diabetologia. 2018;61:1956-1965.
3. Schneider ALC, Selvin E, Sharrett AR, et al. Diabetes, prediabetes, and brain volumes and subclinical cerebrovascular disease on MRI: the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Diabetes Care 2017; 40: 1514–1521.
4. Weinstein G, Davis-Plourde KL, Conner S, et al. Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: pooled analysis from 5 cohorts. PLoS ONE 2019; 14: e0212293.
5. Kullmann S, Kleinridders A, Small DM, et al. Central nervous pathways of insulin action in the control of metabolism and food intake. Lancet Diabetes Endocrinol 2020; 8: 524–534.
6. Tang H, Guo J, Shaaban CE, et al. Heterogeneous treatment effects of metformin on risk of dementia in patients with type 2 diabetes: A longitudinal observational study. Alzheimer’s Dement. 2023;1-11.
7. Cordero MD, Williams MR and Ryffel B. AMP-activated protein kinase regulation of the NLRP3 inflammasome during aging. Trends Endocrinol Metab 2018; 29: 8–17.
8. Madhu LN, Kodali M, Shetty AK. Promise of metformin for preventing age-related cognitive dysfunction.Neural Regen Res. 2022;17:503-507.
9. Chin-Hsiao T. Metformin and the Risk of Dementia in Type 2 Diabetes Patients. Aging Dis. 2019 Feb 1;10(1):37-48. doi: 10.14336/AD.2017.1202.
10. Launer LJ, Miller ME, Williamson JD, et al.; ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011;10:969–977.
11. Luchsinger JA, Ma Y, Christophi CA, et al.; Diabetes Prevention Program Research Group. Metformin, lifestyle intervention, and cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care 2017;40:958–965.
12. Lehtisalo J, Lindstrom J, Ngandu T, et al.; ¨ Finnish Diabetes Prevention Study (DPS). Diabetes, glycaemia, and cognition-a secondary analysis of the Finnish Diabetes Prevention Study. Diabetes Metab Res Rev 2016;32:102–110.
13. Samaras K, Makkar S, Crawford JD, Kochan NA, Wen W, Draper B, et al. Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes : the sydney memory and aging study. Diabetes Care. 2020;43:2691-2701.
14. Zimmerman SC, Ferguson EL, Choudhary V, Ranatunga DK, Oni-Orisan A, PharmD, et al. Metformin cessation and dementia incidence. JAMA Network Open. 2023; 6(10):e2339723.
15. Campbell JM, Stephenson MD, de Courten B, Chapman I, Bellman SM, Aromataris E. Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2018;65(4):1225-1236. doi: 10.3233/JAD-180263.